Are Glycol & Vegetable Oil OK in Your CBD?

You are receiving this as part of your free subscription to Cannabis Profits Daily. To remove your email from this list, [unsubscribe here](. [Cannabis Profits Daily]( Saturday, June 28, 2019 [Q&A: Why Is There Glycol & Vegetable Oil in My CBD?]( By Greg Miller With the CBD market [set to grow 15 times faster]( than the cannabis industry as a whole in 2019, curious individuals are now buying CBD products in CVS, RiteAid, Kroger, and even local gas stations. But if you've never been near cannabis before, how can you be sure what to look for? Some people are looking at the labels for clues, much like our fellow member Janice. Janice P. says: "Thanks for the info on CBD, however, I'd like to know what the ingredients should be. Seen some with glycol and vegetable oils. Shouldn't it be only CBD oil with less than .3% THC? I'm a label reader!" Thanks for the question, Janice. You probably would not want a CBD product where CBD is the only ingredient. CBD oil itself is a sticky mess that's difficult to work with and even more difficult to try to consume. What's more, a dose is only a few milligrams, and measuring that amount out is also difficult. So if you want a tincture or any other liquid product, the CBD must be mixed with something. As you say, the most common mixers are glycol and vegetable oils (the product would separate quickly if water were the mixture). If you prefer one or the other that's fine - the important thing is to get a large enough dose. Many people also choose "full-spectrum" CBD oil - what that means is that, in addition to CBD, the product has other non-psychoactive cannabinoids like CBG, CBN, and the like. And increasingly, products are adding other ingredients to increase the effect, to induce other complementary effects, or to make the tincture more palatable. My CBD oil of choice has a black pepper flower oil, cloves, cumin, the omega-3 fatty acids that come in hemp seeds, and more. Again, these added ingredients are usually helpful or benign, not harmful, and deciding what you want is part of choosing the right product for you. As I've said before, I only recommend stocks for our portfolios when I have inspected the company and found it to have a safe and reliable brand, so that's always [a good place to start](. As more of our members do get started investing in these brands, some of them are still encountering problems with their brokers. J.D. writes: "TD Ameritrade shut down my account because I own a cannabis company. Please consider boycotting these hypocrites and use ETrade instead. Thus far, no issue with them. Same with RBD, they closed my retirement account, so I am moving my money to a Canadian broker." J.D., I fully appreciate your frustration. It's tough to own a cannabis company in the U.S. (as opposed to just cannabis stocks). The banks and brokers fear you because they fear the federal government. The federal banking authorities have made it clear that moving around money attributable to cannabis sales, particularly moving it across state lines, is an excuse for the regulators to make the brokerage firm's life pretty miserable. So I have a little sympathy for these companies. Fortunately, there are bills before Congress to remedy the problem, and they are closer to passing than ever before. I'd encourage you (and anyone in a similar situation) to call your congressperson and demand that they help move forward the [SAFE Banking Act](. Jeff N.: "Keep up the good information. Desperately waiting for my stocks to go up. Please keep that information coming. Any info on Pres. Trump and Congress?" I'm waiting too, Jeff! I'm confident that our stocks will make us a lot of money over time, but that doesn't lessen the frustration of seeing them go down in the meantime! I do think the worst is past us. Congress is making good progress on several bills that would be helpful to the cannabis industry, but of course an obstacle can pop up at any time. So while I'm optimistic, I'm skeptically optimistic until any given bill gets a vote in both the House and Senate. President Donald Trump is a little bit of a mystery. He has made generally pro-cannabis comments in the past, and he was happy to rein in his former Attorney General Jeff Sessions when Sessions rescinded the Cole Memo, which was basically a non-prosecution guide for businesses complying with state law. But he's never been very specific, and cannabis is clearly not something at the front of his thoughts. So again, I'm cautiously optimistic that he'd sign a pro-cannabis piece of legislation if it reaches him, as he said he would with the [STATES Act](. Sooner or later - and more and more people are thinking sooner - the needle is going to shift in favor of the cannabis industry. [Knowing which companies to invest in]( before it does will be your key to a comfortable retirement. [Greg Miller] Greg Miller Executive Director, National Institute for Cannabis Investors [top video] Your Shot at Record-Breaking Profits We've already seen dozens of cannabis companies IPO this year, with one company making history by bringing in [$4.5 billion of brand-new wealth for investors](. But this is just the tip of the iceberg - over the next 10 weeks, we expect to see another [42 companies go public](. And chances are good that their numbers will continue to similarly soar. In fact, each of these companies could easily bring in $5 billion of pure profit for early investors. So if you've been considering getting off the sidelines and doubling down on cannabis investing, there's no better time than now. For all the information you need to get started, [just click right here](. [WATCH]( [our feature benefits] [This landmark event]( was like a shot of adrenaline for the CBD industry. In fact, this catalyst is causing major brands like Coca-Cola, Martha Stewart, Anheuser-Busch, and more to throw their hats into the CBD ring. These big names recognize that CBD can offer them nearly unparalleled profit potential. Analysts are predicting [sales in the hemp CBD market]( will skyrocket over 3,000% in the next three years alone. That would put the sales at $22 billion by 2022 - more than the NFL or online food deliveries generated last year. Our experts want to put this kind of profit potential in your hands, too... which is why they've identified [two breakout CBD companies]( that could deliver 1,000% - or more - profits. For all the details, [just click here](. [JOIN NOW]( [stay connected] [facebook]( [twitter]( [instagram]( [National Institute for Cannabis Investors] You are receiving this e-mail at {EMAIL}, as a part of your subscription to Cannabis Profits Daily. Remove your email from this list: [Unsubscribe]( © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 [Contact Customer Service](mailto:support@nicinvestors.com?subject=Cannabis%20Profits%20Daily%20Question) Website: []( Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. [Privacy Policy]( | [Terms & Conditions](